MARKET INTRODUCTION
Procalcitonin (PCT) is a blood test frequently performed if there is a suspicion of bacterial sepsis, a severe systemic infection that can become life-threatening. The procalcitonin test is an easy way to make the diagnosis quickly and potentially save lives.
MARKET DYNAMICS
High prevalence and rise in incidence rates of sepsis, pneumonia meningitis, and lower respiratory tract infections is expected to boost the usage rate during the forecast period. Moreover, the technological advancements in early detection of procalcitonin levels in the blood such as EIA testing, ELISA testing, and point-of-care testing is likely to create lucrative opportunities during the review period.
MARKET SCOPE
The "Procalcitonin Rapid Test Kit Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of procalcitonin rapid test kit market with detailed market segmentation product, end-user and region. The procalcitonin rapid test kit market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in procalcitonin rapid test kit market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The procalcitonin rapid test kit market is segmented on the basis product, end-user. On the basis of product, the market is segmented into immunoassay test kits, immunochromatography test kits, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic laboratories, physician offices, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Procalcitonin Rapid Test Kit market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Procalcitonin Rapid Test Kit market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Procalcitonin Rapid Test Kit market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Procalcitonin Rapid Test Kit market in these regions.
MARKET PLAYERS
The report covers key developments in the procalcitonin rapid test kit market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from procalcitonin rapid test kit market are anticipated to have lucrative growth opportunities in the future with the rising demand for procalcitonin rapid test kit market in the global market. Below mentioned is the list of few companies engaged in the procalcitonin rapid test kit market.
The report also includes the profiles of key players in procalcitonin rapid test kit market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific
- RayBiotech, Inc.
- Hangzhou Kitgen Biotechnology Co., Ltd.
- Radiometer
- EKF Diagnostics Holdings plc
- Merck KGaA
- Abbott laboratories
- Laboratory Corporation of America Holdings
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Procalcitonin Rapid Test Kit Report Scope
Report Attribute |
Details |
Market size in 2024 |
US$ XX million |
Market Size by 2031 |
US$ XX Million |
Global CAGR (2025 - 2031) |
XX% |
Historical Data |
2021-2023 |
Forecast period |
2025-2031 |
Segments Covered |
By Product - Immunoassay Kits
- Immunochromatography Kits
By End-User - Hospitals
- Diagnostic Laboratories
- Physician Office
|
Regions and Countries Covered |
North America Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
|
Market leaders and key company profiles |
bioMérieux SA
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
RayBiotech, Inc.
Hangzhou Kitgen Biotechnology Co., Ltd.
Radiometer
EKF Diagnostics Holdings plc
Merck KGaA
Abbott laboratories
|